查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1890967

氯沙坦鉀錠市場：依規格、適應症、年齡層、類型、劑型、包裝類型、通路、最終用戶和地區分類

Losartan Potassium Tablets Market, By Strength, By Indication, By Age Group, By Type, By Formulation Type, By Packaging Type, By Distribution Channel, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，氯沙坦鉀錠市值為 26.4 億美元，預計到 2032 年將達到 41.3 億美元，2025 年至 2032 年的複合年成長率為 6.6%。

報告覆蓋範圍 報告詳情
基準年： 2024 2025年市場規模： 26.4億美元
歷史數據時期： 2020-2024 預測期： 2025-2032
預測期間（2025-2032年）： 6.60% 2032 年的預測值： 41.3億美元

全球氯沙坦鉀錠市場是心血管藥物產業的重要組成部分，旨在應對全球高血壓及其相關心血管疾病的流行。氯沙坦鉀是一種血管收縮素受體阻斷劑（ARB），其作用機轉是透過選擇性阻斷血管收縮素II受體，抑制血管收縮和醛固酮分泌，進而降低血壓並改善心血管預後。

由於與ACE抑制劑相比，氯沙坦鉀的副作用較少，尤其是不會引起乾咳，因此備受關注，成為難以耐受降血壓藥物患者的首選治療方案。市場涵蓋多種劑量和劑型，滿足不同地區各類患者的需求。由於全球心血管疾病負擔日益加重、人口老化以及人們對高血壓管理的認知不斷提高，氯沙坦鉀錠的需求持續顯著成長。市場動態受到多種因素的影響，例如專利到期帶來的學名藥藥競爭、新劑型的監管核准、新興國家醫療基礎設施的建設以及主要心臟病學會治療指南的修訂，這些因素共同推動了氯沙坦鉀市場成為更廣泛的抗高血壓治療市場的重要組成部分。

市場動態

全球氯沙坦鉀錠市場受多種強勁因素驅動，呈現穩健成長態勢。主要促進因素包括高血壓盛行率的不斷上升（根據世界衛生組織估計，全球有超過11.3億人患有高血壓），以及人們對心血管風險管理和早期療育策略的日益重視。全球人口老化也是市場擴張的重要因素。高血壓的發生率老齡化成長而顯著增加，而久坐少動、高鈉攝取和壓力等生活方式的改變進一步擴大了需要降血壓治療的患者群體。此外，與ACE抑制劑相比，血管收縮素受體阻斷劑（ARB）具有更優的耐受性，尤其是不會引起血管性水腫和持續性乾咳，這促使醫生更傾向於選擇ARB，並提高了患者的依從性，從而維持了市場需求。

然而，市場也面臨許多阻礙因素。品牌藥專利到期後，學名藥藥的激烈競爭導致藥品價格大幅下降，製造商利潤空間受到擠壓。嚴格的藥品核准和生產合規監管要求也增加了營運成本，延長了研發週期。此外，鈣通道阻斷劑、 BETA阻斷劑新型降血壓藥物以及新型聯合療法的出現，也為市場帶來了擴大市場佔有率的競爭壓力。然而，新興市場（如亞太地區、拉丁美洲和非洲）醫療基礎設施的不斷完善、醫療支出的成長以及藥品可近性的提高，也帶來了巨大的機會。將氯沙坦與其他降血壓藥物共同開發的創新聯合治療，為市場提供了一條盈利的成長途徑；同時，與數位醫療和個人化醫療方法的融合，有望加強病患監測並最佳化治療方案，從而在競爭挑戰下實現市場的長期持續擴張。

本次調查的主要特點

  • 本報告對全球氯沙坦鉀錠市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率。
  • 該報告重點介紹了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與企業。
  • 本報告基於以下幾個方面，對全球氯沙坦鉀片市場的主要企業進行了分析：公司概況、產品系列、主要特徵、財務表現和策略。
  • 本報告的研究結果將使負責人和經營團隊能夠就即將推出的產品、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球氯沙坦鉀片市場報告的目標受眾是該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球氯沙坦鉀片市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特分析
  • 併購趨勢
  • 產業趨勢

4. 2020-2032年全球氯沙坦鉀錠市場（依規格分類）

  • 25mg
  • 50mg
  • 100mg

5. 2020-2032年全球氯沙坦鉀錠市場（依適應症分類）

  • 高血壓
  • 伴隨左心室肥厚（LVH）的高血壓患者
  • 伴有腎臟病的第二型糖尿病

6. 2020-2032年全球氯沙坦鉀錠市場（依年齡層分類）

  • 成人
  • 兒童
  • 老年人

7. 2020-2032年全球氯沙坦鉀錠市場（按類型分類）

  • 品牌
  • 非專利的

8. 2020-2032年全球氯沙坦鉀錠市場（以劑型分類）

  • 速釋片
  • 緩釋片

9. 2020-2032年全球氯沙坦鉀片市場（依包裝類型分類）

  • 泡殼
  • 瓶子
  • 條

10. 2020-2032年全球氯沙坦鉀片市場（依通路分類）

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第11章 全球氯沙坦鉀片市場（依最終用戶分類），2020-2032年

  • 醫院
  • 診所
  • 門診手術中心
  • 居家醫療機構

第12章 2020-2032年全球氯沙坦鉀錠市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第13章 競爭格局

  • Merck（MSD）
  • Teva Pharmaceutical Industries
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Reddy's Laboratories
  • Aurobindo Pharma
  • Lupin Limited
  • Zydus Lifesciences
  • Alembic Pharmaceuticals
  • Viatris（Mylan）
  • Apotex Inc.
  • Hikma Pharmaceuticals
  • Cipla Limited
  • 山德士（諾華旗下部門）
  • Intas Pharmaceuticals

第14章 分析師建議

  • 機會
  • 一致的機會地圖

第15章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8893

Losartan Potassium Tablets Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 4.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.60% 2032 Value Projection: USD 4.13 Bn

The global losartan potassium tablets market represents a crucial segment within the cardiovascular pharmaceutical industry, addressing the widespread prevalence of hypertension and related cardiovascular disorders worldwide. Losartan potassium, an Angiotensin Receptor Blocker (ARB), functions by selectively blocking angiotensin II receptors, thereby preventing vasoconstriction and aldosterone secretion, which ultimately leads to reduced blood pressure and improved cardiovascular outcomes.

This therapeutic class has gained significant traction due to its favorable side effect profile compared to ACE inhibitors, particularly the absence of dry cough, making it a preferred choice for patients with hypertension intolerance issues. The market encompasses various dosage strengths and formulations, catering to diverse patient populations across different geographical regions. With the increasing global burden of cardiovascular diseases, aging demographics, and rising awareness about hypertension management, the demand for Losartan Potassium Tablets continues to expand substantially. The market dynamics are influenced by factors including patent expirations leading to generic competition, regulatory approvals for new formulations, healthcare infrastructure development in emerging economies, and evolving treatment guidelines from major cardiology associations, positioning this market as a vital component of the broader antihypertensive therapeutics landscape.

Market Dynamics

The global losartan potassium tablets market is propelled by several compelling drivers that underscore its robust growth trajectory, with the primary catalyst being the escalating prevalence of hypertension globally, affecting over 1.13 billion people worldwide according to WHO estimates, coupled with increasing awareness about cardiovascular risk management and early intervention strategies. The aging global population demographic significantly contributes to market expansion, as hypertension incidence rises substantially with age, while lifestyle changes including sedentary behavior, high sodium intake, and stress-related factors further amplify the patient pool requiring antihypertensive therapy. Additionally, the superior tolerability profile of ARBs compared to ACE inhibitors, particularly the absence of angioedema and persistent dry cough, drives physician preference and patient compliance, thereby sustaining market demand.

However, the market faces notable restraints including intense generic competition following patent expirations of branded formulations, leading to significant price erosion and margin compression for manufacturers, while stringent regulatory requirements for drug approval and manufacturing compliance impose substantial operational costs and timeline extensions. Furthermore, the availability of alternative antihypertensive classes such as calcium channel blockers, beta-blockers, and newer combination therapies creates competitive pressure on market share growth. Nevertheless, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, and growing pharmaceutical access in emerging markets including Asia-Pacific, Latin America, and Africa. The development of innovative combination therapies incorporating losartan with complementary antihypertensive agents presents lucrative growth avenues, while digital health integration and personalized medicine approaches offer potential for enhanced patient monitoring and treatment optimization, positioning the market for sustained long-term expansion despite competitive challenges.

Key Features of the Study

  • This report provides in-depth analysis of the global losartan potassium tablets market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global losartan potassium tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck and Co. (MSD), Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Lupin Limited, Zydus Lifesciences, Alembic Pharmaceuticals, Viatris (Mylan), Apotex Inc., Hikma Pharmaceuticals, Cipla Limited, Sandoz (Novartis Division), and Intas Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global losartan potassium tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global losartan potassium tablets market

Market Segmentation

  • Strength Insights (Revenue, USD Bn, 2020 - 2032)
    • 25 mg
    • 50 mg
    • 100 mg
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Hypertension
    • Hypertensive Patients with Left Ventricular Hypertrophy (LVH)
    • Type 2 Diabetes with Nephropathy
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Adult
    • Pediatric
    • Geriatric
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Branded
    • Generic
  • Formulation Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Immediate-Release Tablets
    • Extended-Release Tablets
  • Packaging Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Blister Packs
    • Bottles
    • Strip Packs
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Homecare Settings
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck (MSD)
    • Teva Pharmaceutical Industries
    • Torrent Pharmaceuticals
    • Sun Pharmaceutical Industries
    • Reddy's Laboratories
    • Aurobindo Pharma
    • Lupin Limited
    • Zydus Lifesciences
    • Alembic Pharmaceuticals
    • Viatris (Mylan)
    • Apotex Inc.
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Sandoz (Novartis Division)
    • Intas Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Losartan Potassium Tablets Market, By Strength
    • Global Losartan Potassium Tablets Market, By Indication
    • Global Losartan Potassium Tablets Market, By Age Group
    • Global Losartan Potassium Tablets Market, By Type
    • Global Losartan Potassium Tablets Market, By Formulation Type
    • Global Losartan Potassium Tablets Market, By Packaging Type
    • Global Losartan Potassium Tablets Market, By Distribution Channel
    • Global Losartan Potassium Tablets Market, By End User
    • Global Losartan Potassium Tablets Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Losartan Potassium Tablets Market, By Strength, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 25 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 50 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 100 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Losartan Potassium Tablets Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hypertensive Patients with Left Ventricular Hypertrophy (LVH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Type 2 Diabetes with Nephropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Losartan Potassium Tablets Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Losartan Potassium Tablets Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Losartan Potassium Tablets Market, By Formulation Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Immediate-Release Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Extended-Release Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Losartan Potassium Tablets Market, By Packaging Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Blister Packs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Bottles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Strip Packs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Losartan Potassium Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Losartan Potassium Tablets Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Homecare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Losartan Potassium Tablets Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Merck (MSD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Torrent Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aurobindo Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zydus Lifesciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alembic Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Viatris (Mylan)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Apotex Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hikma Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cipla Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sandoz (Novartis Division)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Intas Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us